BUY NOW For Sale 70%!
buy viagra

Viagra to lose patent

By Carly Helfand |

Apr 14, 2015 11:06am

The glory days for Pfizer's ($PFE) Viagra are winding down in the U.S., and now, another generics company has the go-ahead to help pave the way for the drug's demise.

Under a settlement agreement, Mylan ($MYL) is free to launch its copy of the little blue pill as early as Dec.11, 2017--or sooner, under certain conditions, the company said Monday. With that pact, it'll be able to start attacking the blockbuster seller well before its 2020 patent expiration.

And Mylan won't be the only company jumping into the fray. Last December, Teva ($TEVA) inked its own pact to launch a knockoff on Dec. 11, 2017--meaning the two generics heavyweights are in for some serious price competition from the get-go.

That will likely mean a bigger drop in branded sales for Pfizer, which has already gotten a taste of that in ex-U.S. markets. Since 2012, revenue from the pill in the EU, Japan and Australia has shrunk from 2 million to 6 million as the patents there expired.

That's partly because Viagra-copiers came out swinging in those other markets, using price as a selling point. In South Korea, Hanmi Pharmaceuticals advertised its 5,000 won (.25) cost per 100-mg tablet--a third of the cost of the branded med--to win an advantage over the 5 other companies that launched generics within two weeks of Pfizer's patent expiration there. And when Pfizer's IP shield fell in the EU nearly two years ago, industry watchers expected U.K. prices to drop from about £10 a pill to about £1.

If historical patent expirations are any guide, Pfizer will face a tougher battle to hang onto Viagra branded sales with two generics makers in the mix. And in the U.S., Viagra has farther to fall than it did in other countries. Last year, the erectile dysfunction therapy generated .3 billion in Pfizer's home country, according to IMS Health estimates.

- read Mylan's release

Special Report: Top 10 generics makers by 2012 revenue - Mylan - Teva

Read more on
Source: http://www.fiercepharma.com/sales-and-marketing/coming-generics-threat-to-pfizer-s-viagra-brand-just-got-scarier


.
Drug patents expiring in 2017? It s all smoke and mirrors - MedCity Il viagra nel ciclismo

Viagra to lose patent Is Viagra about to lose its pulling power in the UK? Business The
Viagra to lose patent Viagra, Cialis Pull Out of the NFL as Patents End Special Report
Viagra to lose patent Pfizer caught gaming the system, loses Viagra patent in Canada
Viagra to lose patent Top 10 U.S. patent losses of 2017 FiercePharma
Viagra to lose patent 4 Reasons Why Your Husband Doesn't Want Sex
Viagra to lose patent A Plan to Sell Cialis, an Erectile Drug, Over the Counter - The New
Viagra to lose patent Best Over the Counter Viagra - Effective OTC
Boutique de Brets Basque personnaliss - Muse Du Bret Common Side Effects of Flomax (Tamsulosin. - RxList) Exercitii pentru Marirea Rezistentei sexuale Gregg Allman on his 24-year-old fianc : This time, I am Inside the community of men who have given up porn List of Controlled Substances - Drugs Home Page .